Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Crisan-Dabija, T. Mihaescu (Iasi, Romania). Halotherapy – A possible method to enhance airway treatment on patients with obstructive pathology. Eur Respir J 2012; 40: Suppl. 56, 2165

Member's Comments

No comment yet.

Related content which might interest you: Comorbidities associated with chronic obstructive pulmonary disease (COPD) – A clinical study Source: Annual Congress 2011 - COPD diagnosis Year: 2011 Heliox administration in patients with COPD exacerbation – Technical aspects Source: Annual Congress 2010 - Mechanical ventilation and weaning Year: 2010 Daily tele-monitoring of symptoms and spirometry in chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF) – A comparative study Source: Annual Congress 2010 - COPD: diagnosis Year: 2010 Pulmonary rehabilitation in patients with interstitial lung disease – An useful therapeutic option? Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD Year: 2011 The effect of statin therapy in patients with chronic obstructive airway disease Source: International Congress 2015 – COPD: notable points Year: 2015 The influence of inhalation device for bronchodilators on the results of therapy in primary care patients with bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Asthma control or asthma severity Year: 2008 The journey to severe obstructive lung disease – Retrospective study of FEV1 decline Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation Year: 2012 Gender-related differences in non-reversible airways obstruction – results from the Austrian burden of obstructive lung disease (BOLD) study Source: Annual Congress 2009 - Epidemiology of COPD Year: 2009 Emerging anti-inflammatory strategies for COPD}, Source: Eur Respir J 2012; 40: 724-741 Year: 2012 Living with chronic obstructive pulmonary disease (COPD) – A lifeworld perspective Source: Annual Congress 2010 - The nursing challenges and strategies when caring for patients with chronic lung disease Year: 2010 FEV1 decline in patients with chronic obstructive pulmonary disease: Which treatment option is better for slowing of decline? Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 903-908 Year: 2001 Clinical Impact of Gensini score in chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – Monitoring comorbidities Year: 2016 The impact of ²open door² spirometry on diagnosis of obstructive lung diseases Source: Annual Congress 2010 - COPD: diagnosis Year: 2010 Erdosteine – A new drug in the treatment of chronic rhinosinusitis Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use Year: 2012 Doctors‘ awareness of the Gold standard framework (GSF) for palliation in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2012 - The latest insights in chronic care Year: 2012 Assessment of treatment efficiency in patients with chronic obstructive pulmonary disease combined with gastroesophageal reflux disease during treatment with melatonin Source: International Congress 2014 – Clinical presentations Year: 2014 Eosinophilic airway inflammation as a complication of COPD, and the usefulness of ICS on these cases Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Comparison of the effects of smoking and biomass exposure in chronic obstructive pulmonary disease Source: International Congress 2016 – Smoking-related diseases Year: 2016 Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)? Source: Eur Respir J 2001; 18: Suppl. 33, 241s Year: 2001